Ingevity Corp (NGVT) Form 10-Q Quarterly Reports
Ingevity Corp (NGVT) is a publicly traded company on the NYSE, categorized under SIC 2800 (Chemicals & Allied Products). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: NGVT
CIK: 1653477
Exchange: NYSE
SIC 2800: Chemicals & Allied Products
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerAndrew Reinsel
Audit LocationCharlotte, North Carolina, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-02 | 2026-10-01 | FORM 4 | 0002066872-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-10-01 | FORM 4 | 0001575329-26-000011 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-14 | FORM 4 | 0001436880-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-12 | FORM 4 | 0001436880-26-000006 | View SEC Doc Filr Page |
| 144 | 2026-08-12 | — | 144 Filing | 0001950047-26-008035 | View SEC Doc Filr Page |
| 4 | 2026-08-11 | 2026-08-10 | FORM 4 | 0001668926-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-08-03 | FORM 4 | 0002017486-26-000005 | View SEC Doc Filr Page |
| 144 | 2026-08-03 | — | 144 Filing | 0001950047-26-007505 | View SEC Doc Filr Page |
| 10-Q | 2026-07-30 | 2026-06-30 | 10-Q | 0001653477-26-000047 | View SEC Doc Filr Page |
| 8-K | 2026-07-29 | 2026-07-29 | 8-K | 0001653477-26-000044 | View SEC Doc Filr Page |
| 4 | 2026-07-28 | 2026-07-24 | FORM 4 | 0001653477-26-000041 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-07-06 | FORM 4 | 0001653477-26-000039 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-07-01 | FORM 4 | 0001575329-26-000010 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-07-01 | FORM 4 | 0002066872-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2026-06-22 | FORM 4 | 0002142185-26-000004 | View SEC Doc Filr Page |
| 3 | 2026-06-24 | 2026-06-22 | FORM 3 | 0002142185-26-000002 | View SEC Doc Filr Page |
| 8-K | 2026-06-24 | 2026-06-22 | 8-K | 0001653477-26-000037 | View SEC Doc Filr Page |
| 4 | 2026-06-01 | 2026-05-28 | FORM 4 | 0001552446-26-000003 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0000902219-26-000172 | View SEC Doc Filr Page |
| S-8 | 2026-05-07 | — | S-8 | 0001493152-26-021760 | View SEC Doc Filr Page |
| 10-Q | 2026-05-07 | 2026-03-31 | 10-Q | 0001653477-26-000035 | View SEC Doc Filr Page |
| 8-K | 2026-05-06 | 2026-05-06 | 8-K | 0001653477-26-000031 | View SEC Doc Filr Page |
| 4 | 2026-05-05 | 2026-05-01 | FORM 4 | 0001668926-26-000004 | View SEC Doc Filr Page |
| 8-K | 2026-05-04 | 2026-04-29 | 8-K | 0001653477-26-000028 | View SEC Doc Filr Page |
| 4 | 2026-05-01 | 2026-04-30 | FORM 4 | 0001653477-26-000024 | View SEC Doc Filr Page |